Celyad’s Trial Evaluating CAR T-cells in 7 Cancers to Start Enrolling Patients in US
Celyad is ready to enroll patients in its Phase 1…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Kyprolis Significantly Improved Survival of Relapsed Myeloma Patients in Phase 3 Study
Patients with relapsed or refractory multiple myeloma who receive a…
Rabbit Virus Hammers Myeloma in Mice, but Human Use Is a Ways Off
A rabbit virus slowed the growth of multiple myeloma…
Letermovir Prevents CMV Infection, Improves Survival in Bone Marrow Transplant Patients
Patients undergoing hematopoietic (donor) stem cell transplants could benefit…
Finding That Immune Cells Interact Could Lead to Myeloma Therapies, Study Suggests
One kind of immune cell helps another stay active…
FDA OKs Revlimid as Maintenance Therapy in Multiple Myeloma Auto-HSCT Patients
The U.S. Food and Drug Administration has approved the…
